Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Agile Therapeutics Current Ratio 2013-2023 | AGRX

Agile Therapeutics current ratio from 2013 to 2023. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
  
Agile Therapeutics Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2023-12-31 $0.01B $0.02B 0.46
2023-09-30 $0.01B $0.02B 0.57
2023-06-30 $0.01B $0.02B 0.76
2023-03-31 $0.01B $0.02B 0.59
2022-12-31 $0.01B $0.01B 0.85
2022-09-30 $0.02B $0.01B 1.33
2022-06-30 $0.02B $0.03B 0.64
2022-03-31 $0.01B $0.03B 0.56
2021-12-31 $0.02B $0.03B 0.82
2021-09-30 $0.02B $0.01B 2.27
2021-06-30 $0.04B $0.01B 3.18
2021-03-31 $0.04B $0.01B 4.97
2020-12-31 $0.06B $0.01B 7.72
2020-09-30 $0.07B $0.01B 10.18
2020-06-30 $0.09B $0.01B 13.67
2020-03-31 $0.10B $0.00B 33.69
2019-12-31 $0.04B $0.00B 9.31
2019-09-30 $0.02B $0.00B 10.39
2019-06-30 $0.01B $0.00B 6.07
2019-03-31 $0.01B $0.00B 8.91
2018-12-31 $0.01B $0.00B 3.81
2018-09-30 $0.02B $0.01B 2.10
2018-06-30 $0.02B $0.01B 2.19
2018-03-31 $0.03B $0.01B 2.35
2017-12-31 $0.04B $0.01B 2.57
2017-09-30 $0.05B $0.01B 4.10
2017-06-30 $0.03B $0.01B 3.37
2017-03-31 $0.04B $0.01B 3.82
2016-12-31 $0.05B $0.01B 4.70
2016-09-30 $0.06B $0.01B 6.54
2016-06-30 $0.06B $0.01B 6.06
2016-03-31 $0.07B $0.01B 8.15
2015-12-31 $0.04B $0.01B 4.89
2015-09-30 $0.04B $0.01B 5.85
2015-06-30 $0.05B $0.01B 9.02
2015-03-31 $0.05B $0.01B 11.29
2014-12-31 $0.04B $0.01B 4.56
2014-09-30 $0.05B $0.01B 6.50
2014-06-30 $0.05B $0.01B 10.21
2014-03-31 $0.00B 0.00
2013-12-31 $0.00B 0.00
2013-09-30 $0.00B 0.00
2013-06-30 $0.00B 0.00
2012-12-31 $0.02B $0.00B 9.65
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.003B $0.020B
Agile Therapeutics, Inc. is a women's health specialty pharmaceutical company. It is focused on the development and commercialization of new prescription contraceptive products. The Company's lead product candidate is Twirla (TM), also known as AG200-15, a once-weekly prescription contraceptive patch currently in Phase 3 clinical development. Agile Therapeutics, Inc. is headquartered in Princeton, New Jersey.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $14.585B 5.27
Dr Reddy's Laboratories (RDY) India $11.930B 18.86
Aspen Pharmacare (APNHY) South Africa $4.985B 0.00
BridgeBio Pharma (BBIO) United States $4.477B 0.00
Bausch Health Cos (BHC) Canada $3.117B 2.43
Amphastar Pharmaceuticals (AMPH) United States $1.999B 13.68
Supernus Pharmaceuticals (SUPN) United States $1.639B 0.00
Taysha Gene Therapies (TSHA) United States $0.473B 0.00
Generation Bio (GBIO) United States $0.217B 0.00
Assembly Biosciences (ASMB) United States $0.073B 0.00
Personalis (PSNL) United States $0.070B 0.00
Acasti Pharma (ACST) Canada $0.027B 0.00
Sol-Gel Technologies (SLGL) Israel $0.026B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00
Teligent (TLGT) United States $0.000B 0.00